NRI from all over the world (excluding U.S.A. & Canada) can invest in this fund
SBNRI is a certified Mutual Fund distributor registered with Association of Mutual Funds in India (AMFI) with Reg. No. 246671
₹23.22
0.24%
NAV as on 24 Feb 26, 12:00 AM
risk
etf units
equity
NAV as on 24 Feb 26, 12:00 AM
risk
etf units
equity
11.55%p.a.
Last 1Y
24.11%p.a.
Last 3Y
0.00%p.a.
Last 5Y
10.59%p.a.
Since Inception
About Nippon India Nifty Pharma ETF - Growth for NRIs
NRIs can achieve long-term capital appreciation by investing in the Nippon India Nifty Pharma ETF - Growth scheme from Nippon Life India Asset Management Limited. It is a ETF Units mutual fund scheme that predominantly invests in ETF Units stocks of companies. Launched on Jul 2021, Nippon India Nifty Pharma ETF - Growth is ETF Units fund of its category with 1,007.47 Cr fund under management as on Feb 2026. The expense ratio of this fund is less than that of most other Fund category ETF Units funds.
- Nippon India Nifty Pharma ETF - Growth delivered 11.6% annual returns during the last year. It has delivered 10.6% average annual returns since the fund was launched.
- Nippon India Nifty Pharma ETF - Growth scheme tends to consistently deliver higher returns than most schemes in the same category.
- The scheme has predominantly invested in equity
Fund Objective
The Investment Objective Of The Scheme Is To Provide Investment Returns Closely Corresponding To The Total Returns Of The Securities As Represented By The Nifty Pharma Index Before Expenses, Subject To Tracking Errors. However, There Can Be No Assurance Or Guarantee That The Investment Objective Of The Scheme Will Be Achieved.
Top 10 Holdings
Repo
0.19%
Net Payables
-0.15%
Others Mrgn Money
0.00%
Abbott India Ltd
1.81%
Ajanta Pharma Ltd
1.48%
Aurobindo Pharma Ltd
4.26%
Biocon Ltd
3.30%
Zydus Lifesciences Ltd
2.79%
Cipla Ltd
9.39%
Divi's Laboratories Ltd
9.69%
Fund Managers
- Jitendra Tolani (Feb 2025 - Present)
Key Information
View Scheme Document
Nippon India Nifty Pharma ETF - Growth SIP Calculator
If invested
per month
For a period of
Investment of ₹0 could have been
₹0(+0.0%)
₹0 (+0.0%)
This Fund
₹0 (+0.0%)
Fixed Deposit
NRI Mutual Fund Tax on Nippon India Nifty Pharma ETF - Growth
Just like for resident investors, capital gains from mutual fund investments are subject to income tax for NRI investors.
| Fund Type | Short-term Capital Gains (STCG) Tax | Long-term Capital Gains (LTCG) Tax |
|---|---|---|
| Equity mutual funds | 15% | 10% (above Rs. 1 lakh LTCG) without indexation* |
| Debt & other types of funds | At tax slab rate | 20% with indexation benefits |
How can NRIs invest in Nippon India Nifty Pharma ETF - Growth?
NRIs and OCIs can download the SBNRI app to invest in mutual funds from the country of their residence. Here are a few simple steps you need to take:
- Complete your NRI KYC: Type in your personal details and attach supporting documents, like:
- PAN Number
- Overseas address proof: Any of – Water/electricity bill, postpaid mobile/internet bill, rent agreement, driving license, etc.
- Passport – front and back
- Passport size photograph
- signature
If all details are correct, your KYC will be approved within 7 to 8 business days.
- Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing in Nippon India Nifty Pharma ETF - Growth
- Onboarding: After KYC, you need to share the following details to complete onboarding process and start investing:
- City and country of birth
- NRE/NRO bank account statement/ canceled cheque for the latest 3 months
- Nominee details
Similar Funds
Funds
3Y Return
Nippon India Silver ETF - Growth
risk | open-ended
58.2%
CPSE ETF-Growth
risk | equity
38.1%
ICICI Prudential BSE Sensex Exchange Traded Fund
risk | equity
12.7%
Frequently Asked Questions
Copyright | 2021 @ SBNRI | All Rights Reserved